Anicet Mbida delivers to us every morning the best in terms of innovation.

Today, a scientific breakthrough from Denmark for people with diabetes: a "conditional" insulin that only activates when necessary.

Today's innovation should bring some hope to diabetics.

We have just developed a "conditional" insulin.

That is, it activates only when necessary.

Its very important.

You know that insulin helps people with type 1 diabetes lower their blood sugar levels.

But you have to be very careful.

Know exactly when to take it.

Otherwise you risk lowering your blood sugar below recommended levels.

This is called hypoglycemia (and which can be fatal). 

Scientists at the University of Copenhagen in Denmark have just created an insulin that automatically adapts to the level of sugar already present in the blood.

If it is high, normal behavior, the insulin will lower it.

But if the blood sugar is already low, the action of insulin will be reduced so as not to lower the sugar level further.

This avoids any risk of hypoglycemia. 

Is this insulin already available?

Not yet.

Like any medical product, it must pass a battery of tests before being placed on the market.

Which takes time.

In any case, it is very promising.

Because this would also avoid problems of bad dosage. 

There is a lot of innovation currently for the comfort of diabetics.

For example, a watch that monitors blood sugar in real time, without having to pierce the skin.

Or a treatment against type 2 diabetes where you only bite yourself once a week rather than every day (fewer injections, so easier to manage).

A product that will soon be marketed.

Again, this is typical of a current trend in medical research.

No more bleeding in the 16th century, we are looking above all for the least invasive and most comfortable treatments possible.